Sunao Manabe
Amministratore Delegato presso DAIICHI SANKYO CO., LTD.
Posizioni attive di Sunao Manabe
Società | Posizione | Inizio | Fine |
---|---|---|---|
DAIICHI SANKYO CO., LTD. | Amministratore Delegato | 01/06/2019 | - |
Presidente | - | - | |
Direttore/Membro del Consiglio | 01/06/2014 | - | |
Direttore operativo | 01/04/2017 | 01/06/2019 | |
Ufficiale delle Risorse Umane | 01/06/2016 | 01/04/2017 | |
Corporate Officer/Principal | 01/04/2007 | 01/06/2016 | |
Presidente | 01/04/2017 | - | |
Vendite & Marketing | 01/04/2015 | 01/04/2016 | |
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12/07/2023 | - |
Storia della carriera di Sunao Manabe
Statistiche
Distribuzione geografica
Giappone | 2 |
Svizzera | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
DAIICHI SANKYO CO., LTD. | Health Technology |
Aziende private | 1 |
---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
- Borsa valori
- Insiders
- Sunao Manabe
- Esperienza